News for 'kyowa'

Lupin buys Japan's Kyowa Pharma

Indian pharma company Lupin has acquired 80 per cent stake in Kyowa Pharmaceutical Industry (Kyowa), one of the top 10 generic pharmaceutical companies in Japan, for an undisclosed amount.

Lupin, Kyowa Pharma ink deal

Lupin to buy 21 products of Japan's Shionogi for Rs 1,000 cr

This acquisition marks Lupin's foray into the Japanese branded market in-line with aspirations to build business globally.

Lupin sells Japan arm to Unison for Rs 3,702 cr

The company will now focus on specialty products in Japan; it is open to inorganic opportunities, especially in India.

Lupin aims to enter Chinese market in the next one year

Once a difficult market to crack, in recent years, China has relatively opened up its drug market, enacting reforms and speeding up approval time.

Sensex posts biggest single-day gain in nearly 7 years

The rally in index heavyweight ITC has boosted the sentiment across the board.

India-Japan pact hangs in balance over pharma exports

Under MRA, Japan is to recognise Indian medical degrees and treat the country's doctors and other medical personnel on par with its own.